Cue Health (HLTH) announced a new collaboration with Pfizer (PFE) in the U.S. to raise awareness among individuals with certain underlying conditions about the risks of progressing to severe COVID-19 and the importance of seeking treatment if they test positive. Through Cue Care, Cue’s same-day, at-home, test-to-treatment platform, individuals will be able to use the Cue Health App to access educational resources, including information on risk factors for progression to severe illness from COVID-19, including hospitalization or death.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on HLTH:
